Literature DB >> 35137262

[68 Ga]Ga-FAPI versus [18F]F-FDG in malignant melanoma: complementary or counterpoint?

Kgomotso Mokoala1, Novruzov Emil2, Ismaheel Lawal1,3, Christina Antke2, Frederik L Giesel2, Mike Sathekge4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35137262     DOI： 10.1007/s00259-022-05702-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   10.057


× No keyword cloud information.
  5 in total

1.  Activation of cancer-associated fibroblasts is required for tumor neovascularization in a murine model of melanoma.

Authors:  James Hutchenreuther; Krista Vincent; Chris Norley; Michael Racanelli; Stephen B Gruber; Timothy M Johnson; Douglas R Fullen; Leon Raskin; Bernard Perbal; David W Holdsworth; Lynne-Marie Postovit; Andrew Leask
Journal:  Matrix Biol       Date:  2018-06-07       Impact factor: 11.583

2.  Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein.

Authors:  Thomas Lindner; Anastasia Loktev; Annette Altmann; Frederik Giesel; Clemens Kratochwil; Jürgen Debus; Dirk Jäger; Walter Mier; Uwe Haberkorn
Journal:  J Nucl Med       Date:  2018-04-06       Impact factor: 10.057

3.  Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention.

Authors:  Anastasia Loktev; Thomas Lindner; Eva-Maria Burger; Annette Altmann; Frederik Giesel; Clemens Kratochwil; Jürgen Debus; Frederik Marmé; Dirk Jäger; Walter Mier; Uwe Haberkorn
Journal:  J Nucl Med       Date:  2019-03-08       Impact factor: 10.057

Review 4.  Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape.

Authors:  Veronica Romano; Immacolata Belviso; Alessandro Venuta; Maria Rosaria Ruocco; Stefania Masone; Federica Aliotta; Giuseppe Fiume; Stefania Montagnani; Angelica Avagliano; Alessandro Arcucci
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

5.  68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers.

Authors:  Frederik L Giesel; Clemens Kratochwil; Thomas Lindner; Manfred M Marschalek; Anastasia Loktev; Wencke Lehnert; Jürgen Debus; Dirk Jäger; Paul Flechsig; Annette Altmann; Walter Mier; Uwe Haberkorn
Journal:  J Nucl Med       Date:  2018-08-02       Impact factor: 10.057
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.